AR043171A1 - Sal de cetilpiridinio de un agente antiinflamatorio, composiciones farmaceuticas que la contienen y un procedimiento para la preparacion de la sal. - Google Patents

Sal de cetilpiridinio de un agente antiinflamatorio, composiciones farmaceuticas que la contienen y un procedimiento para la preparacion de la sal.

Info

Publication number
AR043171A1
AR043171A1 ARP040100444A ARP040100444A AR043171A1 AR 043171 A1 AR043171 A1 AR 043171A1 AR P040100444 A ARP040100444 A AR P040100444A AR P040100444 A ARP040100444 A AR P040100444A AR 043171 A1 AR043171 A1 AR 043171A1
Authority
AR
Argentina
Prior art keywords
salt
preparation
pharmaceutical compositions
compositions containing
cetilpiridinio
Prior art date
Application number
ARP040100444A
Other languages
English (en)
Inventor
Giorgio Pifferi
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of AR043171A1 publication Critical patent/AR043171A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/18—Salts thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20—Quaternary compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/40—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/42—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to carbon atoms of at least one six-membered aromatic ring and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton with carboxyl groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by saturated carbon chains

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Sal de diclofenac y cetilpiridinio. Composiciones farmacéuticas que los contienen en dosis eficaces, para ser utilizados como antiinflamatorios. Reivindicación 1: Sal de diclofenac y cetilpiridinio de fórmula (1). Reivindicación 3: Procedimiento que comprende la preparación de la sal de diclofenac y cetilpirinio (I) según el esquema (2), donde: X es H o un catión inorgánico u orgánico, e Y es OH o halógeno, en un solvente adecuado y la separación de la sal (I) así obtenida mediante técnicas tradicionales.
ARP040100444A 2003-02-14 2004-02-13 Sal de cetilpiridinio de un agente antiinflamatorio, composiciones farmaceuticas que la contienen y un procedimiento para la preparacion de la sal. AR043171A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000269A ITMI20030269A1 (it) 2003-02-14 2003-02-14 Sale di cetilpiridino di un agente antiinfiammatorio

Publications (1)

Publication Number Publication Date
AR043171A1 true AR043171A1 (es) 2005-07-20

Family

ID=32866065

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100444A AR043171A1 (es) 2003-02-14 2004-02-13 Sal de cetilpiridinio de un agente antiinflamatorio, composiciones farmaceuticas que la contienen y un procedimiento para la preparacion de la sal.

Country Status (16)

Country Link
US (1) US7250428B2 (es)
EP (1) EP1592657A1 (es)
JP (1) JP2006517565A (es)
KR (1) KR20050101186A (es)
CN (1) CN1318389C (es)
AR (1) AR043171A1 (es)
AU (1) AU2004212154A1 (es)
CA (1) CA2511900A1 (es)
EA (1) EA008003B1 (es)
GE (1) GEP20064009B (es)
HK (1) HK1080449A1 (es)
IL (1) IL169312A (es)
IT (1) ITMI20030269A1 (es)
MX (1) MXPA05008589A (es)
PL (1) PL376362A1 (es)
WO (1) WO2004072017A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2011009010A1 (en) * 2009-07-15 2011-01-20 University Of Medicine And Dentistry Of New Jersey Novel compounds for inhibiting eef2 kinase activity
KR101666659B1 (ko) * 2014-06-12 2016-10-14 한국생명공학연구원 부틸 피리디늄 또는 이의 유도체를 포함하는 근력약화 관련 질환의 예방 또는 치료용 약학적 조성물
JP7214331B2 (ja) * 2016-12-28 2023-01-30 小林製薬株式会社 医薬組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT370721B (de) * 1981-02-24 1983-04-25 Ciba Geigy Ag Verfahren zur herstellung von neuen salzen der 2- (2,6-dichloranilino)-phenylessigsaeure, der
IT1228242B (it) * 1986-11-13 1991-06-05 Ricerfarma Srl Milano Sale del diclofenac con idrossietilpirrolidina e composizioni farmaceutiche che lo contengono
IT1250636B (it) * 1991-07-04 1995-04-21 Ricerche Di Schiena Del Dr Mic Sale del diclofenac, metodo di preparazione e composizioni farmaceutiche che lo contengono.
US5614223A (en) * 1992-05-04 1997-03-25 Digestive Care Inc. Intraoral medicament-releasing device
ATE268186T1 (de) * 1994-06-06 2004-06-15 Thejmde Trust Biotinverbindungen zum zielen auf tumore und infektionsherde
DE19856101A1 (de) * 1998-12-04 2000-06-08 Labtec Gmbh Mundhöhlen-Matrixpflaster
JP2000256186A (ja) * 1999-03-05 2000-09-19 Taisho Pharmaceut Co Ltd 咽頭疾患用組成物

Also Published As

Publication number Publication date
CA2511900A1 (en) 2004-08-26
PL376362A1 (en) 2005-12-27
MXPA05008589A (es) 2005-11-04
ITMI20030269A1 (it) 2004-08-15
EA008003B1 (ru) 2007-02-27
HK1080449A1 (zh) 2006-04-28
AU2004212154A1 (en) 2004-08-26
WO2004072017A1 (en) 2004-08-26
EP1592657A1 (en) 2005-11-09
IL169312A0 (en) 2007-07-04
IL169312A (en) 2010-05-17
KR20050101186A (ko) 2005-10-20
CN1318389C (zh) 2007-05-30
GEP20064009B (en) 2006-12-25
CN1745061A (zh) 2006-03-08
EA200501088A1 (ru) 2005-12-29
US20060142353A1 (en) 2006-06-29
JP2006517565A (ja) 2006-07-27
US7250428B2 (en) 2007-07-31

Similar Documents

Publication Publication Date Title
CL2004000293A1 (es) Compuestos derivados de dihidrofenantridin-sulfonamidas sustituidas, sus sales; procedimiento de preparacion; composicion farmaceutica; compuestos intermediarios; y su uso en el tratamiento de la diabetes tipo ii, alzheimer, demencia senil, asma, col
DOP2006000084A (es) Compuestos sulfoximino-macrociclicos y sus sales, composiciones farmaceuticas que comprenden dichos compuestos, metodos de preparacion y usos de los mismos
UY27740A1 (es) Nuevos compuestos
AR082825A2 (es) Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios
AR048017A1 (es) Composicion y metodo para aumentar la biodisponibilidad
BR0213612A (pt) Composto, composição farmacêutica, uso do composto e método para tratamento de doença ou condição
UY29886A1 (es) Derivados de pirazol novedosos, composiciones farmaccuticas que los contienen, procedimientos para la preparacinn de los mismos y aplicaciones
UY29343A1 (es) Pirazolopiridinas y sales de las mismas, una composición farmacéutica que comprende dichos compuestos, un método para prepararlos y su uso.
ECSP066653A (es) Derivados de bencenosulfonilamino-piridin-2-il y compuestos relacionados como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1(ii-beta-hsd-1) para el tratamiento de la diabetes y de la obesidad
UY29085A1 (es) Derivados de pirimidina 4-sulfonamido sustituidos, compuestos intermedios para su preparación, procedimientos de preparación, composiciones medicinales conteniéndolos y aplicaci0nes
BRPI0516454A (pt) compostos, processo para a preparação de um composto, composição farmacêutica que o compreende, sua utilização, método para o tratamento e profilaxia de enfermidades, e de diabetes do tipo ii
UY27872A1 (es) Inhibidores de caspasa y usos de los mismos.
UY28979A1 (es) Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
BR0012951A (pt) Agonistas de retinóides seletivos
BR112017017211A2 (pt) composto, composição, sal farmaceuticamente aceitável de um composto, combinação, formulação farmacêutica, métodos para matar uma micobactéria e/ou inibir a replicação de micobactérias que causam doença em um animal, para tratamento de uma infecção micobacteriana em um animal e para tratamento de uma doença resultante de uma infecção por micobactéria de um mamífero, e, uso de um composto.
PA8542601A1 (es) Bifenilcarboxamidas reductoras de lipidos
AR069749A1 (es) Proceso de dehidrohalogenacion para la preparacion de intermediarios utiles en el suministro de compuestos 6,6- dimetil-3-azabiciclo -(3.1.0)- hexano
CL2004000979A1 (es) Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida.
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
ES2096973T3 (es) Fosfazenos que contienen radicales organicos de silicio, proceso para su preparacion, y su empleo.
AR046874A1 (es) Nuevos metodos
GT199900081A (es) Compuestos de sulfonilbenceno como agentes anti-inflamatorios / analgesicos.
AR029461A1 (es) Derivados de 4-fenil-1-piperazinilo, - piperidinilo y -tetrahidropiridilo , composiciones farmaceuticas que los comprenden y el uso de los mismos para la fabricacion de un medicamento
CO2024002844A2 (es) Compuestos espirocíclicos

Legal Events

Date Code Title Description
FA Abandonment or withdrawal